Tag

The Fenway Institute

Study Explores Less Invasive Options For Transmasculine Sexual Health Screening

By | Education, Fenway Health Newsroom, Health Care, LGBT Health, Research, The Fenway Institute, Trans | No Comments
Female-to-male (FTM) transgender men and transmasculine individuals are people who are assigned female at birth but identify as male or as masculine. Many FTM transgender men and transmasculine individuals are born with reproductive organs typically labeled as female (e.g. cervix), and most FTM transgender men and transmasculine individuals do not choose to undergo a full hysterectomy (removal of the uterus, cervix, fallopian tubes, and ovaries).1 Because of this, many FTM and transmasculine people are at risk for cervical cancer, human papillomavirus (HPV), as well as other sexually transmitted infections (STIs) and may not realize it. It is recommended that anybody 
Read More

Volunteers Needed For New PrEP Study That Could Revolutionize HIV Prevention

By | Fenway Health Newsroom, HIV/AIDS, HIV/AIDS, Research, The Fenway Institute | No Comments
Increased public awareness and use of pre-exposure prophylaxis (PrEP) has been tremendously powerful in the global battle against HIV/AIDS. Studies have shown that, when taken as a daily pill, PrEP is 92-99% effective at preventing HIV infections in HIV-negative individuals. However, as with any daily medication, strict adherence is the key to success – and, for many people, this may become a barrier to PrEP’s effectiveness. The Fenway Institute is serving as a site for a new study, HPTN 083, that explores whether injectable, long-acting PrEP, is a viable alternative to oral PrEP. Injectable PrEP has the potential to truly 
Read More

Registration Open For Fenway’s Third Annual Transgender Health Conference

By | Education, Fenway Health Newsroom, Fenway News, Health Care, The Fenway Institute, Trans | No Comments
Fenway Health invites you to join us for our annual “Advancing Excellence in Transgender Health” Conference from October 13 to 14, 2017. This year’s conference is being offered as a national course accredited by Harvard Medical School. Local and nationally-recognized experts will train the whole health care team in providing competent and confident gender-affirmative health care, grounded in research evidence and best clinical practices. The conference is produced by our team of medical, mental health, and health research experts. The conference program includes foundational material for all members of health care teams as well as specialized content for both medical 
Read More

Lieutenant Shachar Erez Visits Fenway

By | Fenway Health Newsroom, News, The Fenway Institute, Trans | No Comments
The Fenway Institute was excited to host Lieutenant Shachar Erez today at our 1340 Boylston St. offices. Shown in the above photo with The Fenway Institute’s Dr. Sean Cahill, Director of Health Policy Research, and Cheri Callanan, Community Education Specialist at The LGBT Aging Project, Lt. Shachar visited today to discuss transgender issues in the Israeli military and in Israeli society and learn about Fenway Health’s transgender health work. Lt. Erez is the first openly transgender commander in the Israeli Defense Forces. He transitioned while serving in the military, receiving support from his unit and commanders.Lt. Shachar’s work has helped 
Read More

HIV Vaccines Could Vastly Improve HIV Prevention – And You Can Help

By | Fenway Health Newsroom, HIV/AIDS, HIV/AIDS, The Fenway Institute | No Comments
There were a reported 2.1 million new HIV infections in 2015, and 36.7 million people are currently living with HIV/AIDS globally. Vaccines could be an incredibly powerful tool in the fight against HIV/AIDS, with the potential to dramatically reduce the number of new HIV infections around the world. In continuation of Fenway Health’s decades-long commitment to treating and preventing HIV/AIDS, The Fenway Institute is excited to serve as a study site for several HIV vaccine trials, including HVTN 108. HVTN 108 will examine both tolerability of a new HIV vaccine and the immune system’s response to it. It’s important to 
Read More